Findings

What do systematic reviews say?

3 questions · 3 findings · 3 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 33.3%Low 1 · 33.3%Moderate 0 · 0%High 1 · 33.3%

Antiplatelet drug vs control

Pulmonary embolism · acute ischaemic stroke

It is very uncertain whether antiplatelet drug changes pulmonary embolism during treatment period compared with control (very low certainty).

1 finding from 1 review

Oral antiplatelet therapy for acute ischaemic stroke 2022 · Cochrane Headline outcomes only
Peto OR 0.71 [0.53, 0.96]
7 studies · 41042 participants
Very low

Anticoagulant vs control

Symptomatic PE · acute presumed ischaemic stroke

Summary of findings table ‐ Anticoagulant leads to lower symptomatic pulmonary embolism during treatment period compared with control (high certainty).

1 finding from 1 review

Anticoagulants for acute ischaemic stroke 2021 · Cochrane Headline outcomes only
OR 0.6 [0.44, 0.81]
14 studies · 22544 participants
High

Low‐molecular‐weight heparins or heparinoids vs unfractionated heparin

Pulmonary embolism · acute ischaemic stroke

Low‐molecular‐weight heparins or heparinoids showed no clear difference in pulmonary embolism during treatment period (range 6 days to 16 days) compared with unfractionated heparin (low certainty).

1 finding from 1 review

Low‐molecular‐weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke 2017 · Cochrane Headline outcomes only
OR 0.57 [0.23, 1.41]
6 studies · 1250 participants
Low